Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Luiz Paulo Chaves"'
Autor:
Camila Morais Melo, Thiago Vidotto, Luiz Paulo Chaves, William Lautert-Dutra, Rodolfo Borges dos Reis, Jeremy Andrew Squire
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 17, p 9550 (2021)
Immunotherapy has improved patient survival in many types of cancer, but for prostate cancer, initial results with immunotherapy have been disappointing. Prostate cancer is considered an immunologically excluded or cold tumor, unable to generate an e
Externí odkaz:
https://doaj.org/article/17e04779afec4784bc38e0490f5c09ee
Autor:
William Lautert-Dutra, Camila Morais Melo, Luiz Paulo Chaves, André Luiz Caliari, Francisco Cesar Souza Silva, Jeremy Andrew Squire
Publikováno v:
Cancer Research. 82:6099-6099
Prostate Cancer (PCa) is considered an immunologically excluded tumor, unable to generate an effective T-cell response against cancer cells. Inactivating mutations of the PTEN tumor suppressor are one of the most common events in human malignancies t
Autor:
Luiz Paulo Chaves, André Luiz Caliari, William Lautert-Dutra, Francisco Cesar Souza Silva, Camila Morais Melo, Fabiano Pinto Saggioro, Rodolfo Borges dos Reis, Jeremy Andrew Squire
Publikováno v:
Cancer Research. 82:6098-6098
Prostate cancer (PCa) reactivates a latent embryonic program called epithelial-mesenchymal transition during disease progression. The mesenchymal phenotype contributes to invasion, metastasis and therapy response variation. In this study, we characte
Autor:
Rodolfo Borges dos Reis, Jeremy A. Squire, Luiz Paulo Chaves, Thiago Vidotto, William Lautert-Dutra, Camila Morais Melo
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
International Journal of Molecular Sciences, Vol 22, Iss 9550, p 9550 (2021)
International Journal of Molecular Sciences
Universidade de São Paulo (USP)
instacron:USP
International Journal of Molecular Sciences, Vol 22, Iss 9550, p 9550 (2021)
International Journal of Molecular Sciences
Immunotherapy has improved patient survival in many types of cancer, but for prostate cancer, initial results with immunotherapy have been disappointing. Prostate cancer is considered an immunologically excluded or cold tumor, unable to generate an e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b833ce6b7e73a2330bab52c3a0b383ea